Company Q2M Biotech AG Deutsche Boerse AG
Equities
DE000A0HL8J7
Business Support Services
End-of-day quote
Other stock markets
|
||
- EUR | - |
Business Summary
Sales per Business
EUR in Million | 2017 | Weight | 2018 | Weight | Delta |
---|---|---|---|---|---|
Management Consultancy
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +28.70% |
Sales per region
EUR in Million | 2017 | Weight | 2018 | Weight | Delta |
---|---|---|---|---|---|
Germany
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +28.70% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Elke Etzel
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Stefan Zenzen
CHM | Chairman | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 553,514 | 553,514 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-32.78% | 3.18B | |
+9.02% | 2.74B | |
-1.66% | 1.56B | |
-11.74% | 1.06B | |
+20.79% | 835M | |
-9.59% | 701M | |
-5.09% | 597M | |
-12.47% | 582M | |
-12.97% | 520M |
- Stock Market
- Equities
- QBI Stock
- Stock
- Company Q2M Biotech AG